The use of PK Papyrus covered coronary stent for carotid reconstruction: an initial institutional experience.
The use of PK Papyrus covered coronary stent for carotid reconstruction: an initial institutional experience. J Neurointerv Surg. 2024 Nov 22; 16(12):1244-1249.
PMID: 38171608
Use of Onyx Frontier™ for intracranial stenting in stroke patients: A multicenter retrospective study.
Use of Onyx Frontier™ for intracranial stenting in stroke patients: A multicenter retrospective study. Interv Neuroradiol. 2024 Oct 21; 15910199241286922.
PMID: 39429004
Association of Hemometabolic Trajectory and Mortality: Insights From the Cardiogenic Shock Working Group Registry.
Association of Hemometabolic Trajectory and Mortality: Insights From the Cardiogenic Shock Working Group Registry. J Card Fail. 2024 Oct; 30(10):1196-1207.
PMID: 39389726
Contemporary Saphenous Vein Graft Intervention: New Insights but Still More Questions.
Contemporary Saphenous Vein Graft Intervention: New Insights but Still More Questions. J Soc Cardiovasc Angiogr Interv. 2024 Oct; 3(10):102282.
PMID: 39525992
Prevalence of Coronary Microvascular Dysfunction and Epicardial Spasm in Patients With Angina and Myocardial Bridge.
Prevalence of Coronary Microvascular Dysfunction and Epicardial Spasm in Patients With Angina and Myocardial Bridge. J Soc Cardiovasc Angiogr Interv. 2024 Sep; 3(9):102196.
PMID: 39575216
Serial Shock Severity Assessment Within 72 Hours After Diagnosis: A Cardiogenic Shock Working Group Report.
Serial Shock Severity Assessment Within 72 Hours After Diagnosis: A Cardiogenic Shock Working Group Report. J Am Coll Cardiol. 2024 Aug 01.
PMID: 39217545
Prognostic Implications of Quantifying Vasoactive Medications in Cardiogenic Shock.
Prognostic Implications of Quantifying Vasoactive Medications in Cardiogenic Shock. J Card Fail. 2024 Nov; 30(11):1516-1521.
PMID: 39002848
Factors associated with acute limb ischemia in cardiogenic shock and downstream clinical outcomes: Insights from the Cardiogenic Shock Working Group.
Factors associated with acute limb ischemia in cardiogenic shock and downstream clinical outcomes: Insights from the Cardiogenic Shock Working Group. J Heart Lung Transplant. 2024 Nov; 43(11):1846-1856.
PMID: 38944132
Clinical outcomes among cardiogenic shock patients supported with high-capacity Impella axial flow pumps: A report from the Cardiogenic Shock Working Group.
Clinical outcomes among cardiogenic shock patients supported with high-capacity Impella axial flow pumps: A report from the Cardiogenic Shock Working Group. J Heart Lung Transplant. 2024 Sep; 43(9):1478-1488.
PMID: 38834162
Angiographic Coronary Slow Flow Is Not a Valid Surrogate for Invasively Diagnosed Coronary Microvascular Dysfunction.
Angiographic Coronary Slow Flow Is Not a Valid Surrogate for Invasively Diagnosed Coronary Microvascular Dysfunction. JACC Cardiovasc Interv. 2024 Apr 08; 17(7):920-929.
PMID: 38599696